Torpedo Maculopathy: Case Series of an Underdiagnosed and Rare Condition Using Multimodal Imaging

Background

Torpedo maculopathy (TM) is a rare congenital anomaly firstly reported by Roseman and Gass in 1992 as a solitary hypopigmented nevus of the retinal pigment epithelium (RPE) [1]. It typically presents as a well-defined, flat, bullet-shaped lesion, located temporal to the macula and pointing towards it [2]. In the vast majority of cases, this anomaly is unilateral, asymptomatic, and nonprogressive and most of the time, the lesion is discovered incidentally and remains benign over time, although rare cases of neovascularization have been described [3].

Despite its specific characteristics, this disease is sometimes misdiagnosed and referred to retina centers for further assessment. In the era of multimodal imaging, it is important to find the key diagnostic feature to help clinicians recognize this benign lesion and avoid unnecessary investigations. In this study, the authors present a retrospective series of five patients with TM with systematic analysis of lesions on color fundus photography, fundus short wavelength autofluorescence (FAF), SD-OCT, and OCTA aiming to improve its early recognition.

Publication History

Received: 22 October 2023

Accepted: 02 January 2024

Accepted Manuscript online:
04 January 2024

Article published online:
26 March 2024

• References

• 1 Roseman RL, Gass JD. Solitary hypopigmented nevus of the retinal pigment epithelium in the macula. Arch Ophthalmol 1992; 110: 1358-1359 DOI: 10.1001/archopht.1992.01080220020005.
• 2 Golchet PR, Jampol LM, Mathura JR. et al. Torpedo maculopathy. Br J Ophthalmol 2010; 94: 302-306 DOI: 10.1136/bjo.2009.162669.
• 3 Shirley K, OʼNeill M, Gamble R. et al. Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population. Eye (Lond) 2018; 32: 1315-1320 DOI: 10.1038/s41433-018-0074-7.
• 4 Wong EN, Fraser-Bell S, Hunyor AP. et al. Novel optical coherence tomography classification of torpedo maculopathy. Clin Exp Ophthalmol 2015; 43: 342-348 DOI: 10.1111/ceo.12435.
• 5 Richez F, Gueudry J, Brasseur G. et al. [Bilateral torpedo maculopathy]. J Fr Ophtalmol 2010; 33: 296 DOI: 10.1016/j.jfo.2009.12.013.
• 6 Knani L, Werda S, Ghachem M. et al. Multimodal imaging of torpedo maculopathy with optical coherence tomography angiography. Saudi J Ophthalmol 2023; 37: 63-65 DOI: 10.4103/sjopt.sjopt_9_21.
• 7 Venkatesh R, Jain K, Pereira A. et al. Torpedo Retinopathy. J Ophthalmic Vis Res 2020; 15: 187-194 DOI: 10.18502/jovr.v15i2.6736.
• 8 Raju B, Nooyi C, Raju NSD. et al. Torpedo maculopathy with double torpedoes. Indian J Ophthalmol 2018; 66: 1189-1190 DOI: 10.4103/ijo.IJO_192_18.
• 9 Grimaldi G, Scupola A, Sammarco MG. et al. Morpho-functional evaluation of torpedo maculopathy with optical coherence tomography angiography and microperimetry. Am J Ophthalmol Case Rep 2018; 10: 165-168 DOI: 10.1016/j.ajoc.2018.02.019.
• 10 Tripathy K, Sarma B, Mazumdar S. Commentary: Inner retinal excavation in torpedo maculopathy and proposed type 3 lesions in optical coherence tomography. Indian J Ophthalmol 2018; 66: 1213-1214 DOI: 10.4103/ijo.IJO_656_18.
• 11 Papastefanou VP, Vázquez-Alfageme C, Keane PA. et al. Multimodality imaging of torpedo maculopathy with swept-source, en face optical coherence tomography and optical coherence tomography angiography. Retin Cases Brief Rep 2018; 12: 153-157 DOI: 10.1097/ICB.0000000000000456.
• 12 Hamm C, Shechtman D, Reynolds S. A deeper look at torpedo maculopathy. Clin Exp Optom 2017; 100: 563-568 DOI: 10.1111/cxo.12540.